Realizing the promise of apoptosis-based therapies: separating the living from the clinically undead
- 2 May 2003
- journal article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 10 (5) , 493-495
- https://doi.org/10.1038/sj.cdd.4401217
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Distinct downstream pathways of caspase-11 in regulating apoptosis and cytokine maturation during septic shock responseCell Death & Differentiation, 2002
- Sphingosine 1-phosphate as a therapeutic agentLeukemia, 2002
- Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor AgonistsScience, 2002
- Inhibition of Myocardial Apoptosis as a Therapeutic Target in Cardiovascular Disease PreventionHeart Disease, 2001
- APOPTOSIS AND DISEASE: Regulation and Clinical Relevance of Programmed Cell DeathAnnual Review of Medicine, 1997
- Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphateNature, 1996
- Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting EnzymeScience, 1995
- Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shockCell, 1995
- STERILITY AND CYCLOPHOSPHAMIDEThe Lancet, 1972
- Multiple late complications of therapy with cyclophosphamide, including ovarian destructionThe American Journal of Medicine, 1971